As pharmaceutical manufacturers face growing scrutiny over drug costs and increasingly sophisticated purchasers, demonstrating a product’s value has become central to commercialization. Strong clinical results alone may not be enough to secure access and adoption.

Manufacturers need to translate evidence into a clear, compelling narrative tailored to different decision-makers. Doing so requires understanding what each audience values, shaping the story accordingly and equipping teams to communicate it effectively.